{"disease":{"id":"writing-disorder","name":"writing disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05355480","title":"Handwriting Analysis in Movement Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Neuromed IRCCS","has_results":false},{"nct_id":"NCT06858566","title":"Impact of the Kaligo Solution on Learning to Write in Children Aged 6 to 11 With Handwriting Disorders : KALIGO+","phase":"NA","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Fondation Ildys","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}